Product Information
NAPROXEN 375 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.0561 per EA under NDC 68462018905. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 28, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
375 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462018905
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NAPROXENApproval Type
Generic (ANDA)
FDA Application
ANDA078250FDA Approved
3/28/2007
TE Code
AB
On Market Since
7/1/2007
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN 375 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0561 per EA |
|---|---|
| All-time high | $0.0808 (Jun 16, 2021) |
| All-time low | $0.0435 (Mar 18, 2015) |
| 52-week high | $0.0607 |
| 52-week low | $0.0561 |
| Median price | $0.0624 |
| Average price | $0.0635 |
| Largest weekly change | +36.8% (Apr 22, 2015) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPROXEN 375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 375 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.0561 per EA (NDC 68462018905), effective Aug 19, 2026.
How has the price of NAPROXEN 375 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN 375 MG TABLET has risen 18.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NAPROXEN 375 MG TABLET?
Since Nov 28, 2013, the NADAC for NAPROXEN 375 MG TABLET has ranged from a low of $0.0435 (Mar 18, 2015) to a high of $0.0808 (Jun 16, 2021), with a median of $0.0624 per EA.
Are there cheaper alternatives to NAPROXEN 375 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NAPROXEN 375 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NAPROXEN 375 MG TABLET?
NAPROXEN 375 MG TABLET (NDC 68462018905) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.